Elderwin Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.30 M
- Company Age 5 Year, 23 Days
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 25.15%
- Profit Growth -84.05%
- Ebitda -81.04%
- Net Worth 6.95%
- Total Assets 5.35%
About Elderwin Laboratories
Elderwin Laboratories Private Limited (ELPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 21 January 2020 (Five years 23 days old ). Its registered office is in Bardhaman, West Bengal, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.30 M, as per Ministry of Corporate Affairs (MCA) records.
Himanshu Biswas, Minhajuddin Molla, and Sekh Giasuddin serve as directors at the Company.
Company Details
-
Location
Bardhaman, West Bengal, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24100WB2020PTC236048
-
Company No.
236048
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
21 Jan 2020
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Elderwin Laboratories?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Himanshu Biswas
|
Director | 20-Oct-2020 | Current |
|
Minhajuddin Molla
|
Director | 20-Oct-2020 | Current |
|
Sekh Giasuddin
|
Director | 21-Jan-2020 | Current |
Financial Performance of Elderwin Laboratories.
Elderwin Laboratories Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 25.15% increase. The company also saw a substantial fall in profitability, with a 84.05% decrease in profit. The company's net worth moved up by a moderate rise of 6.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Elderwin Laboratories?
Unlock access to Elderwin Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Elderwin Laboratories?
Unlock and access historical data on people associated with Elderwin Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Elderwin Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Elderwin Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
